10,000 stroke patients enrolled in Real-World tenecteplase study across china
NCT ID NCT07271342
First seen Jan 05, 2026 · Last updated May 10, 2026 · Updated 23 times
Summary
This study is observing about 10,000 adults who have had a stroke and received the clot-busting drug tenecteplase as part of their normal care. Researchers will track their recovery and any side effects for 90 days to see how well the drug works in real-world settings across many hospitals in China. The goal is to gather information to improve stroke treatment nationwide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital, Capital Medical University
RECRUITINGBeijing, 100070, China
Conditions
Explore the condition pages connected to this study.